Human molecular chronotyping in sight?
© BioMed Central Ltd 2004
Published: 1 November 2004
Recent research on mouse models has taken us closer to deciphering the molecular clock mechanism that defines an individual's 'body time'. How feasible will it be to create a molecular timetable that allows determination of individual body time from tissue harvested at a single time point?
All human beings have in common the characteristic of going to sleep at night and waking up in the morning automatically. As we stumble into a new day, the body prepares itself for the new tasks ahead and increases heart rate, blood pressure and temperature; conversely, these parameters decrease in the evening. Such daily occurring rhythms with a period of about 24 hours are termed circadian rhythms, because they manifest themselves even under constant conditions - that is, even in the absence of stimuli that recur with a 24 hour periodicity, such as daylight. The length of the circadian period is relatively unaffected by changes in temperature or nutritional state. Its phase, however, can be synchronized, or 'entrained', to the environment by light, food or temperature.
It is thought that the circadian timing system provides a benefit to the organism by providing a temporal structure across the body so as to modulate and synchronize biological function and to prevent activation of biochemical pathways that have adverse effects on each other. During the day catabolic processes facilitate engagement with the environment, whereas at night anabolic functions of growth, repair and consolidation predominate (reviewed in ). It is evident that medical treatment elicits responses from the body that are dependent on its internal time. Hence, medical treatment can have adverse effects on the patient when it is given at the 'wrong' hour of the day [2, 3]. This makes it essential to determine body time if we are to maximize the benefits of medical treatment. It is of great interest to understand how the circadian clock works at the molecular level and how to use this information to generate a molecular timetable that allows profiling of an individual's biochemical pathways in time. Over the past few years significant progress towards this end has been made using animal models. In this article I briefly describe the molecular mechanism of the clock in mammals and then discuss a microarray-based method, proposed by Ueda et al.  for determining body time.
The molecular circadian oscillator and some of its targets
The genes involved in the molecular feedback-loop described in Figure 1 could be viewed as analogous to the cogwheels of a wristwatch. Without hands such a clock would not be of great use. Similarly, the circadian clock must somehow interact with biochemical pathways that produce physiological circadian rhythms in the organism. The obvious assumption is that some of the molecular clock components interact or activate genes involved in the relevant biochemical pathways. The search for E-box enhancer elements in the promoters of potentially important proteins, and examination of their transcriptional regulation by Clock and Bmal1, has led to the identification of several clock-controlled genes. Among these are the arginine vasopressin gene (Avp), D-element-binding protein (Dbp), type 1 adenylyl cyclase (AC1) and the cell-cycle regulator wee1. Of note is that Dbp can regulate expression of members of the cytochrome P45O family, such as cholesterol 7α-hydroxylase, and can impose a circadian activation pattern on these genes as a result of its own circadian regulation by Clock/Bmal1 . Hence, such genes are regulated indirectly by Clock/Bmal1 via Dbp. A change in clock parameters will therefore not affect all circadian-expressed genes in the same manner, and this complicates the idea of creating a unifying time-course gene-expression map for different individuals within a population.
Determination of body time: chronotyping
Although the human body is regulated by a complex network of processes ordered along the timeline of a 24 hour day, the phase of the 24 hour oscillations can vary between individuals, as is evident from the observation that in every society we find some individuals behaving as larks and others as owls. This poses a problem for generalized medicine. Whereas a specific medical treatment schedule can have positive effects for a 'lark' type of person, the very same therapy can have negative consequences for an 'owl' type of person . This is not only an anecdotal issue: it is demonstrated by the finding that altering the timing of chemotherapy increases its efficiency . To tailor the timing for a therapy such as chemotherapy for a single human being, it is of interest to determine the phase of the clock in the body relative to a reference time, such as the mean of the population's clock phase. Hence, an individual's internal body time reveals the chronotype (lark or owl) of that person. When referring to timings within the diurnal cycle of an individual's clock, researchers use the concept of zeitgeber time (ZT), in which ZT is 0 at the beginning of the light phase (day).
This method does not only allow determination of individual body time, it is also useful to reveal gross alterations in the functioning of the circadian clock. Ueda et al.  demonstrated this for mice mutant for the Clock gene. The expression levels of the genes from the molecular timetable plotted as a function of the MPT are scattered and no cosine curve can be fitted through the data points (Figure 2d), indicating a disrupted clock mechanism. This is consistent with the loss of circadian wheel-running behavior in constant darkness that is observed in these mice .
It appears that this method opens enormous possibilities for individual chronotyping, but for the moment we have to view this approach with a grain of salt. First, Ueda et al.  have shown the feasibility of this method in mice, where tissue is easily accessible and large quantities can be used for experimentation; will it work for humans? Second, the choice of tissue seems to be important. As revealed by a number of microarray studies, most tissues display phase-specific patterns of clock and clock-controlled gene expression (reviewed in ). For example in the heart most of the circadian-expressed genes peak around ZT = 2 , whereas in fibroblast cells ZT = 6 and ZT = 22 are the most frequently observed peak times . This makes it more difficult to select genes suitable for the molecular timetable, because it is important that the genes evaluated are evenly represented over time so that the cosine curve fitting is not biased towards a specific group of genes over-representing an MPT. Ueda et al.  used liver tissue in their proof-of-principle experiment, and this is the tissue with the most homogenous distribution of MPTs of different genes. But, they also applied the molecular timetable method to brain tissue and in particular to tissue from the suprachiasmatic nucleus (SCN), a structure in the ventral part of the hypothalamus that contains a circadian clock that can coordinate the clocks found in other tissues. MPTs in the SCN are not evenly distributed, but are clustered at dawn (ZT = 22) and dusk (ZT = 10) . This clustering can also be seen in the data for SCN tissue provided by Ueda et al.  (in their supplemental Figure 8). In the cosine curve fitting, MPT 0 and MPT 14 are strongly under-represented, leading to a larger error in cosine curve fitting and hence the method is less precise for SCN tissue than for liver.
It is evident that the reliability of the molecular timetable method depends crucially on the genes selected. One would expect that the clock components shown in Figure 1 are good candidates to be part of that timetable. But, comparing these genes with the table constructed by Ueda et al.  for mouse liver (162 genes) and mouse SCN (96 genes), only Per2 and Cry1 are included in the liver timetable, whereas Per1, Per2, Cry1, Rorα and Dbp are included in the SCN timetable. The reason for the higher representation of clock genes in the SCN table might be the absence of strongly oscillating genes that peak at times other than those of the main clock components shown in Figure 1. Their maximal expression is observed at ZT = 6-8 (Per1), ZT = 8-12 (Per2), ZT = 12 (Cry1), ZT = 6 (Rorα) and ZT = 12 (Dbp). In the liver, however, a large number of metabolic enzymes are part of the timetable, including alcohol dehydrogenase, several enzymes of the cytochrome P450 family, aminolaevulinate synthase 1, fatty acid synthase and hydroxymethylglutaryl-CoA synthase 1. Some of these genes are indirectly regulated by the clock (as discussed above), which might be a reason for a more even distribution of MPTs in the liver timetable. It is nevertheless astonishing that more clock genes are not included. One interpretation of this finding could be that transcription factors other than those shown in Figure 1 play a major role in driving clock gene expression in the liver. This idea is supported by the observation that several uncharacterized genes are part of the liver timetable.
In summary Ueda et al.  have demonstrated that the molecular timetable method is applicable for mice. Even in a mouse strain with a heterogenous genetic background the method allows the estimation of body time, albeit with less precision than in mice of homogenous genetic background. The greatest challenge for the future will be in tailoring the method for humans. Tissue collection will be a major constraint, given that it is practically not possible to get liver tissue (the best suited for the analysis) nor SCN tissue from humans. More easily accessible tissues, such as buccal tissue or skin fibroblasts, must therefore be considered. The next step will be to select suitable genes in these tissues representing the whole 24 hours of a day in the heterogenous human population. Large numbers must be analyzed, so as to establish a standard to which individual samples can be compared. A complementary approach to body time estimation would be determination of an individual's clock period by culturing their fibroblasts. Because clock oscillation can be monitored in single cells  using marker genes indicated in Figure 1, the period length of an individual's clock can be derived. The phase of the clock relative to a standard - that is, the individual body time - can not be determined with this method, however. Real-time PCR offers another possibility not only for determining the clock period but also body time. Compared to the molecular timetable method, a PCR-based method for amplifying a few clock genes would need several tissue samples taken at different times. For example, buccal swabs taken every two to three hours from an individual would be suitable for constructing an individual's circadian expression curve for a particular clock gene. For all such methods a common crucial factor is standardization of tissue sampling. Human clock phase is strongly influenced not only by illumination, temperature and social factors but also, for example, by exercise . To gain reproducible and comparable results external factors have to be excluded using constant routine protocols [16, 17]: a person will have to be in isolation for a period of time. This illustrates the huge effort that will have to be made if we are to achieve precise individual chronotyping. But we can hope that characterization of human chronotypes using gene-expression-based methods will facilitate diagnosis of circadian rhythm disorders and might support the development of chronotherapy and personalized medicine, as long as the above-mentioned difficulties can be overcome.
I thank Gurudutt Pendyala and Andrea Küthe for comments on the manuscript. I am supported by the Swiss National Science Foundation (3100AO-104222/1), the Bundesamt für Bildung und Wissenschaft (BBW) with EC grant BrainTime (QLG3-CT-2002-01829) and the State of Fribourg.
- Hastings MH, Reddy AB, Maywood ES: A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003, 4: 649-661. 10.1038/nrn1177.PubMedView ArticleGoogle Scholar
- Levi F, Zidani R, Misset J: Randomised multicentre trial of chronotherapy with oxaplatin, fluorouracil, and folic acid in metastatic colorectal cancer. Lancet. 1997, 350: 681-686. 10.1016/S0140-6736(97)03358-8.PubMedView ArticleGoogle Scholar
- Ohdo S, Koyanagi S, Suyama H, Higuchi S, Aramaki H: Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nat Med. 2001, 7: 356-360. 10.1038/85507.PubMedView ArticleGoogle Scholar
- Ueda HR, Chen W, Minami Y, Honma S, Honma K, Iino M, Hashimoto S: Molecular-timetable methods for detection of body time and rhythm disorders form single-time-point genome-wide expression profiles. Proc Natl Acad Sci USA. 2004, 101: 11227-11232. 10.1073/pnas.0401882101.PubMedPubMed CentralView ArticleGoogle Scholar
- Young MW, Kay SA: Time zones: a comparative genetics of circadian clocks. Nat Rev Genet. 2001, 2: 702-715. 10.1038/35088576.PubMedView ArticleGoogle Scholar
- Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptacek LJ, Fu Y-H: An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science. 2001, 291: 1040-1043. 10.1126/science.1057499.PubMedView ArticleGoogle Scholar
- Lavery DJ, Lopez-Molina L, Margueron R, Fleury-Olela F, Conquet F, Schibler U, Bonfils C: Circadian expression of the steroid 15 α-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP. Mol Cell Biol. 1999, 19: 6488-6499.PubMedPubMed CentralView ArticleGoogle Scholar
- Reinberg A, Halberg F: Circadian chronopharmacology. Annu Rev Pharmacol. 1971, 11: 455-492.PubMedView ArticleGoogle Scholar
- Vitaterna MH, King DP, Chang A-M, Kornhauser JM, Lowery PL, McDonald JD, Dove WF, Pinto LH, Turek FW, Takahashi JS: Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science. 1994, 264: 719-725.PubMedPubMed CentralView ArticleGoogle Scholar
- Duffield GE: DNA microarray analyses of circadian timing: the genomic basis of biological time. J Neuroendocrinol. 2003, 15: 991-1002. 10.1046/j.1365-2826.2003.01082.x.PubMedView ArticleGoogle Scholar
- Storch K-F, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, Weitz CJ: Extensive and divergent circadian gene expression in liver and heart. Nature. 2002, 417: 78-83. 10.1038/nature744.PubMedView ArticleGoogle Scholar
- Duffield GE, Best JD, Meurers BH, Bittner A, Loros JJ, Dunlap JC: Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells. Curr Biol. 2002, 12: 551-557. 10.1016/S0960-9822(02)00765-0.PubMedView ArticleGoogle Scholar
- Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB: Coordinated transcription of key pathways in the mouse by the circadian clock. Cell. 2002, 109: 307-320. 10.1016/S0092-8674(02)00722-5.PubMedView ArticleGoogle Scholar
- Balsalobre A, Damiola F, Schibler U: A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell. 1998, 93: 929-937. 10.1016/S0092-8674(00)81199-X.PubMedView ArticleGoogle Scholar
- Zambon AC, McDearmon EL, Salomonis N, Vranizan KM, Johansen KL, Adey D, Takahashi JS, Schambelan M, Conklin BR: Time- and exercise-dependent gene regulation in human skeletal muscle. Genome Biol. 2003, 4: R61-10.1186/gb-2003-4-10-r61.PubMedPubMed CentralView ArticleGoogle Scholar
- Mills JN, Minors DS, Waterhouse JM: Adaptation to abrupt time shifts of the oscillator controlling human circadian rhythms. J Physiol. 1978, 285: 455-470.PubMedPubMed CentralView ArticleGoogle Scholar
- Czeisler CA, Brown EN, Ronda JM, Kronauer RE: A clinical method to assess the endogenous circadian phase (ECP) of the deep circadian oscillator in man. Sleep. 1985, 14: 295-Google Scholar